HRP20040623B1 - Method for producing scopine esters - Google Patents

Method for producing scopine esters

Info

Publication number
HRP20040623B1
HRP20040623B1 HRP20040623AA HRP20040623A HRP20040623B1 HR P20040623 B1 HRP20040623 B1 HR P20040623B1 HR P20040623A A HRP20040623A A HR P20040623AA HR P20040623 A HRP20040623 A HR P20040623A HR P20040623 B1 HRP20040623 B1 HR P20040623B1
Authority
HR
Croatia
Prior art keywords
bromine
chlorine
hydroxy
formula
group
Prior art date
Application number
HRP20040623AA
Other languages
English (en)
Croatian (hr)
Inventor
Brandenburg J�rg
Pfrengle Waldemar
Rall Werner
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of HRP20040623A2 publication Critical patent/HRP20040623A2/hr
Publication of HRP20040623B1 publication Critical patent/HRP20040623B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polyethers (AREA)
HRP20040623AA 2002-01-12 2004-07-09 Method for producing scopine esters HRP20040623B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10200943A DE10200943A1 (de) 2002-01-12 2002-01-12 Verfahren zur Herstellung von Scopinestern
PCT/EP2002/014756 WO2003057694A1 (de) 2002-01-12 2002-12-24 Verfahren zur herstellung von scopinestern

Publications (2)

Publication Number Publication Date
HRP20040623A2 HRP20040623A2 (en) 2005-04-30
HRP20040623B1 true HRP20040623B1 (en) 2012-09-30

Family

ID=7711974

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040623AA HRP20040623B1 (en) 2002-01-12 2004-07-09 Method for producing scopine esters

Country Status (31)

Country Link
US (1) US6747154B2 (ja)
EP (2) EP1467993B1 (ja)
JP (1) JP5134756B2 (ja)
KR (1) KR100929503B1 (ja)
CN (1) CN100406456C (ja)
AT (1) ATE404557T1 (ja)
AU (1) AU2002361218B2 (ja)
BR (1) BR0215493A (ja)
CA (1) CA2471755C (ja)
CO (1) CO5601006A2 (ja)
CY (1) CY1108471T1 (ja)
DE (2) DE10200943A1 (ja)
DK (1) DK1467993T3 (ja)
EA (1) EA007230B1 (ja)
EC (1) ECSP045182A (ja)
ES (1) ES2312655T3 (ja)
HK (1) HK1073847A1 (ja)
HR (1) HRP20040623B1 (ja)
HU (1) HU226665B1 (ja)
IL (2) IL162416A0 (ja)
ME (1) MEP51208A (ja)
MX (1) MXPA04006677A (ja)
NO (1) NO328825B1 (ja)
NZ (1) NZ534339A (ja)
PL (1) PL208132B1 (ja)
PT (1) PT1467993E (ja)
RS (1) RS50771B (ja)
SI (1) SI1467993T1 (ja)
UA (1) UA78753C2 (ja)
WO (1) WO2003057694A1 (ja)
ZA (1) ZA200403852B (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
DE10216427A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
CA2495275C (en) * 2002-08-14 2012-04-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic agent
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
RS51758B (en) * 2003-11-03 2011-12-31 Boehringer Ingelheim International Gmbh. PROCEDURE FOR OBTAINING SALT TIOTROPIUM
ATE478071T1 (de) * 2003-11-03 2010-09-15 Boehringer Ingelheim Int Verfahren zur herstellung neuer tiotropiumsalze
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
DK1881980T3 (da) * 2005-05-02 2012-10-01 Boehringer Ingelheim Int Nye krystalline former af tiotropiumbromid
CN101227905A (zh) * 2005-06-15 2008-07-23 贝林格尔·英格海姆国际有限公司 制备噻托铵盐的方法、噻托铵盐及其药物组合物
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
CN101208316B (zh) * 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
EP1997819A1 (de) * 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopinestern
AU2009203579B2 (en) * 2008-01-10 2013-07-25 Generics [Uk] Limited Novel process for the preparation of scopine esters
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
EP2462140A2 (en) 2009-08-07 2012-06-13 Generics [UK] Limited Anhydrate of triotropium bromide
US8957209B2 (en) 2010-04-01 2015-02-17 Mahmut Bilgic Methods for the synthesis of tiotropium bromide
TR201005221A2 (tr) * 2010-04-01 2012-01-23 Bi̇lgi̇ç Mahmut Geliştirilmiş sentez metodu.
TR201002520A2 (tr) * 2010-04-01 2010-05-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür imalat metodu.
TR201005222A2 (tr) * 2010-04-01 2011-10-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür sentez yöntemi
ITRM20110508A1 (it) 2011-09-27 2013-03-28 Lusochimica Spa Processo per la preparazione degli esteri della scopina.
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
CZ304808B6 (cs) 2012-03-16 2014-11-05 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu a jeho nová forma
CZ305012B6 (cs) 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418716A1 (de) * 1989-09-16 1991-03-27 Boehringer Ingelheim Kg Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
WO1992016528A1 (de) * 1991-03-15 1992-10-01 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
AU690257B2 (en) * 1994-04-19 1998-04-23 Neurosearch A/S Tropane-2-alcoxime derivatives as neurotransmitter reuptake inhibitors
DE19515625C2 (de) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
WO1998016528A1 (en) * 1996-10-11 1998-04-23 Chiron Corporation Purine inhibitors of glycogen synthase kinase 3 (gsk3)
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418716A1 (de) * 1989-09-16 1991-03-27 Boehringer Ingelheim Kg Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
WO1992016528A1 (de) * 1991-03-15 1992-10-01 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Also Published As

Publication number Publication date
MEP51208A (en) 2011-05-10
ES2312655T3 (es) 2009-03-01
KR20040072715A (ko) 2004-08-18
RS50771B (sr) 2010-08-31
EA200400875A1 (ru) 2004-12-30
MXPA04006677A (es) 2004-10-04
US20030232993A1 (en) 2003-12-18
US6747154B2 (en) 2004-06-08
HUP0402604A2 (hu) 2005-04-28
HK1073847A1 (en) 2005-10-21
IL162416A0 (en) 2005-11-20
WO2003057694A1 (de) 2003-07-17
HRP20040623A2 (en) 2005-04-30
KR100929503B1 (ko) 2009-12-03
PL369126A1 (en) 2005-04-18
AU2002361218B2 (en) 2008-04-24
DE10200943A1 (de) 2003-07-24
EP1972626A3 (de) 2008-10-01
DK1467993T3 (da) 2008-11-10
PT1467993E (pt) 2008-09-03
PL208132B1 (pl) 2011-03-31
DE50212650D1 (de) 2008-09-25
NO328825B1 (no) 2010-05-25
SI1467993T1 (sl) 2009-02-28
CA2471755A1 (en) 2003-07-17
NZ534339A (en) 2005-04-29
ZA200403852B (en) 2005-06-22
EP1972626A2 (de) 2008-09-24
NO20043341L (no) 2004-08-11
JP5134756B2 (ja) 2013-01-30
BR0215493A (pt) 2004-12-28
HU226665B1 (en) 2009-06-29
RS59404A (en) 2007-04-10
CO5601006A2 (es) 2006-01-31
CN1610680A (zh) 2005-04-27
IL162416A (en) 2010-06-30
JP2005519890A (ja) 2005-07-07
ECSP045182A (es) 2004-08-27
EA007230B1 (ru) 2006-08-25
ATE404557T1 (de) 2008-08-15
CA2471755C (en) 2011-02-08
UA78753C2 (en) 2007-04-25
HUP0402604A3 (en) 2008-05-28
CY1108471T1 (el) 2014-04-09
EP1467993B1 (de) 2008-08-13
CN100406456C (zh) 2008-07-30
EP1467993A1 (de) 2004-10-20
AU2002361218A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
HRP20040623B1 (en) Method for producing scopine esters
PE20061099A1 (es) Compuestos de piridil acido acetico como inhibidores de peptidasa
TW200640859A (en) Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
PE20070121A1 (es) 2,4-diamino-pirimidinas como inhibidores de aurora
ECSP067100A (es) Preparación enantioselectiva del derivado de quinolina
MY142018A (en) Thiophene derivatives as chk 1 inihibitors
EP1881051A4 (en) PROCESS FOR MANUFACTURING COKE OF HIGH STOVE
PE20060598A1 (es) Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5
NO20075626L (no) Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes
DE602005007864D1 (de) Modifizierung von erdalkalimetallsilicatfasern
MY157871A (en) Mapk/erk kinase inhibitors
EP1854795A4 (en) SALT OF A PROLIN DERIVATIVE, SOLVAT THEREOF AND METHOD FOR THE PRODUCTION THEREOF
ATE557020T1 (de) Alkyl-3-ä2-(benzoäbüthiophen-5-yl)-ethoxyü- propanoate als intermediate in der herstellung von azetidin-3-ol derivativen
GB0600763D0 (en) 6, 7-dihydrobenzimidazo[1,2-C]quininazolin-6-one carboxylic acid, its esters and method of synthesis thereof
NO20070089L (no) DPP-IV inhibitorer
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
BRPI0517909A (pt) cloridrato de (s)-(-)-1-(4-fluorisoquinolin-5-il)sulfonil-2-metil-1,4-ho mopiperazino diidratado
TW200722913A (en) Dye-containing curable composition, color filter and method of producing thereof
PE20081195A1 (es) Derivado de 2-piridincarboxamida que tiene efecto activador de gk
TW200718688A (en) Fluorinated ryridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
EP1568665A3 (en) An optical glass for precision molding
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
ATE452135T1 (de) Herstellungsverfahren für silylisocyanurat

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20111219

Year of fee payment: 10

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20121225